Live Breaking News & Updates on Kite Pharmaceuticals|Page 3

Stay updated with breaking news from Kite pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

PM360 Magazine Announces Winners of 2021 Trailblazer Awards

PM360 Magazine Announces Winners of 2021 Trailblazer Awards
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United States , Patrickl Sutton , Rozita Passarella , Dave Guiga , Melanie Nicholson , Jeff Laconte , Chen Boehringer Ingelheim , Anna Stashower , Angela Guh , Qbfox Healthcomm , Hillarym Titus , Zimmer Biomet , Christine Kingsbury , Bristol Myers Squibb , Depuy Synthes , Paul Vega , Mike Goeren , Enbrel Amgen , Megan Shultis , Joe George , Zoe Cohen , Paul Lowman , Judy Gold , Nicole Yohn , Kevin Conway , Larry Mcnally ,

Chimeric Therapeutics Ltd appoints COO Jennifer Chow as new CEO and MD

Chimeric Therapeutics Ltd appoints COO Jennifer Chow as new CEO and MD
proactiveinvestors.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com.au Daily Mail and Mail on Sunday newspapers.

Paul Hopper , Jennifer Chow , Nycomed Takeda , Kite Pharmaceuticals , Gilead Sciences ,

HepaTx appoints Salah Kivlighn as new CEO


HepaTx appoints Salah Kivlighn as new CEO
News provided by
Share this article
Share this article
PALO ALTO, Calif., April 15, 2021 /PRNewswire/  HepaTx Corporation, a preclinical stage company developing cell therapies for the treatment of liver disease, is pleased to announce the appointment of Salah Kivlighn, PhD as Chief Executive Office. An experienced business leader, Dr. Kivlighn will succeed Co-founder Eric Schuur, PhD and assume responsibilities on April 15
th, 2021.
Dr. Kivlighn brings a rare blend of science and business acumen to HepaTx. His experience spans therapeutic classes including oncology, vaccines, immuno-oncology, and cardiovascular disease treatments and multiple aspects of drug development and commercialization. His accomplishments include: guided the discovery, evolution, and commercialization of Losartan (Cozaar®), a market-leading antihypertensive drug becoming a $3.5B franchise (Merck & Co.); co-led the development and commerc ....

Eric Schuur , Salah Kivlighn , Losartan Cozaar , Arthur Guyton , Medimmune Astrazeneca , States Pharmacopeia , Kite Pharmaceuticals , Merck Co , Hepatx Corporation , University Of Houston , Chief Executive , Co Founder Eric Schuur , Recently Salah , United States Pharmacopeia , Commercial Vice President , Chief Executive Officer Award , Prix Galien Award , New Biotechnology , ஆர்தர் பையன் , மாநிலங்களில் மருந்தகம் , காத்தாடி மருந்துகள் , மெர்க் இணை , பல்கலைக்கழகம் ஆஃப் ஹூஸ்டன் , தலைமை நிர்வாகி , ஒன்றுபட்டது மாநிலங்களில் மருந்தகம் , வணிகரீதியானது துணை ப்ரெஸிடெஂட் ,